JP2017507741A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017507741A5 JP2017507741A5 JP2016556946A JP2016556946A JP2017507741A5 JP 2017507741 A5 JP2017507741 A5 JP 2017507741A5 JP 2016556946 A JP2016556946 A JP 2016556946A JP 2016556946 A JP2016556946 A JP 2016556946A JP 2017507741 A5 JP2017507741 A5 JP 2017507741A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic agent
- organic additive
- medical device
- coating layer
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 30
- 239000006259 organic additive Substances 0.000 claims 25
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 18
- 239000011247 coating layer Substances 0.000 claims 14
- LXCFILQKKLGQFO-UHFFFAOYSA-N Methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims 10
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims 10
- 229960005137 Succinic Acid Drugs 0.000 claims 9
- 239000007787 solid Substances 0.000 claims 9
- 239000001384 succinic acid Substances 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 8
- RCINICONZNJXQF-MZXODVADSA-N Intaxel Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 6
- 229960001592 Paclitaxel Drugs 0.000 claims 6
- 229930003347 taxol Natural products 0.000 claims 6
- 210000001519 tissues Anatomy 0.000 claims 6
- 229960001948 caffeine Drugs 0.000 claims 5
- VBIGULIJWJPALH-UHFFFAOYSA-L calcium;2-carboxyphenolate Chemical compound [Ca+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O VBIGULIJWJPALH-UHFFFAOYSA-L 0.000 claims 5
- 239000011248 coating agent Substances 0.000 claims 5
- 238000000576 coating method Methods 0.000 claims 5
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims 5
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims 5
- 229960002216 methylparaben Drugs 0.000 claims 5
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-Aminobenzoic acid Chemical group NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N Adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims 4
- JFCQEDHGNNZCLN-UHFFFAOYSA-N Glutaric acid Chemical compound OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 claims 4
- CVHZOJJKTDOEJC-UHFFFAOYSA-N Saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims 4
- YAPQBXQYLJRXSA-UHFFFAOYSA-N Theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 claims 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N Theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 claims 4
- 229960004050 aminobenzoic acid Drugs 0.000 claims 4
- 229940079593 drugs Drugs 0.000 claims 4
- 238000010998 test method Methods 0.000 claims 4
- 239000000155 melt Substances 0.000 claims 3
- 238000002844 melting Methods 0.000 claims 3
- 229940022659 Acetaminophen Drugs 0.000 claims 2
- 229940109239 Creatinine Drugs 0.000 claims 2
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 claims 2
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 claims 2
- 239000004677 Nylon Substances 0.000 claims 2
- 229940067082 Pentetate Drugs 0.000 claims 2
- 229940081974 Saccharin Drugs 0.000 claims 2
- 229960004559 Theobromine Drugs 0.000 claims 2
- 229960000278 Theophylline Drugs 0.000 claims 2
- 229960004799 Tryptophan Drugs 0.000 claims 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 2
- 229960001138 acetylsalicylic acid Drugs 0.000 claims 2
- 229960000250 adipic acid Drugs 0.000 claims 2
- 239000001361 adipic acid Substances 0.000 claims 2
- 235000011037 adipic acid Nutrition 0.000 claims 2
- 235000010323 ascorbic acid Nutrition 0.000 claims 2
- 229960005070 ascorbic acid Drugs 0.000 claims 2
- 239000011668 ascorbic acid Substances 0.000 claims 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims 2
- RYECOJGRJDOGPP-UHFFFAOYSA-N ethylurea Chemical compound CCNC(N)=O RYECOJGRJDOGPP-UHFFFAOYSA-N 0.000 claims 2
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 claims 2
- 229920001778 nylon Polymers 0.000 claims 2
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims 2
- 229960005489 paracetamol Drugs 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- 235000019204 saccharin Nutrition 0.000 claims 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims 2
- 230000001954 sterilising Effects 0.000 claims 2
- 238000004659 sterilization and disinfection Methods 0.000 claims 2
- 230000005944 tissue migration Effects 0.000 claims 2
- 239000005711 Benzoic acid Substances 0.000 claims 1
- 210000004204 Blood Vessels Anatomy 0.000 claims 1
- 230000001070 adhesive Effects 0.000 claims 1
- 230000015556 catabolic process Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000004059 degradation Effects 0.000 claims 1
- 238000006731 degradation reaction Methods 0.000 claims 1
- 239000000374 eutectic mixture Substances 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 239000010410 layer Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 200000000008 restenosis Diseases 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 200000000009 stenosis Diseases 0.000 claims 1
- 230000036262 stenosis Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Claims (24)
- 組織に治療剤を送達するための医療機器であって、該機器は機器の表面に適用された固体界面活性剤不含粒子状コーティング層を有し、該コーティング層は治療剤及び少なくとも1つの加水分解安定性である非ポリマー有機添加剤を含み、治療剤及び少なくとも1つの有機添加剤を含む粒子状コーティング層の少なくとも一部分は治療剤及び少なくとも1つの有機添加剤の純粋な形態の際の融点よりも低い温度で単一相として融解し、該治療剤はパクリタキセルであり、そして該治療剤がコーティング層中に配合されたときに、該治療剤は無菌化に対して安定である、医療機器。
- 前記粒子状コーティング層は機器に適用された治療剤及び少なくとも1つの有機添加剤の溶液を蒸発させることにより形成され、固体粒子状組成物を形成する、請求項1に記載の医療機器。
- 前記治療剤及び少なくとも1つの有機添加剤の前記溶液は水、アセトン及びそれらの混合物から選ばれる溶媒中の溶液である、請求項2記載の医療機器。
- 前記粒子状コーティング中の前記治療剤及び少なくとも1つの有機添加剤は結晶形態である、請求項1〜3のいずれか1項記載の医療機器。
- 少なくとも1つの有機添加剤の各々は純粋な形態の際に約80℃より高い温度で融解する、請求項1〜4のいずれか1項記載の医療機器。
- 前記コーティング層は共融混合物で治療剤及び少なくとも1つの有機添加剤の結晶性粒子を含む、請求項1〜5のいずれか1項記載の医療機器。
- 前記コーティング層は共結晶形態で治療剤及び少なくとも1つの有機添加剤の結晶性粒子を含む、請求項1〜5のいずれか1項記載の医療機器。
- 少なくとも1つの有機添加剤の各々は、p-アミノ安息香酸、サッカリン、アスコルビン酸、メチルパラベン、カフェイン、サリチル酸カルシウム、ペンテト酸、クレアチニン、エチル尿素、アセトアミノフェン、アスピリン、テオブロミン、トリプトファン、コハク酸、アジピン酸、グルタル酸、テオフィリン及びサッカリンナトリウムからなる群より独立して選ばれ、例えば、少なくとも1つの有機添加剤の各々は、p-アミノ安息香酸、メチルパラベン、カフェイン、サリチル酸カルシウム及びコハク酸からなる群より独立して選ばれ、特には、コハク酸である、請求項1〜7のいずれか1項記載の医療機器。
- 前記コーティング層は治療剤及び1つの有機添加剤からなる、請求項1〜8のいずれか1項記載の医療機器。
- 前記固体コーティング層はナイロン又はePTFEからなる機器の表面に適用される、請求項1〜9のいずれか1項記載の医療機器。
- 組織に治療剤を送達するための医療機器であって、該機器は機器の外側表面に適用された固体粒子状コーティング層を有し、該表面はナイロン及びePTFEから選ばれる材料からなり、該コーティング層は治療剤及び少なくとも1つの有機添加剤を含み、治療剤及び少なくとも1つの有機添加剤を含む粒子状コーティング層の少なくとも一部分は治療剤及び少なくとも1つの有機添加剤の純粋な形態の際の融点よりも低い温度で単一相として融解し、該治療剤はパクリタキセルであり、そして該少なくとも1つの有機添加剤はサリチル酸カルシウム、カフェイン、メチルパラベン、p-アミノ安息香酸及びコハク酸からなる群より独立して選ばれる、医療機器。
- 前記コーティング層は治療剤及び1つの有機添加剤からなる、請求項11記載の医療機器。
- 前記有機添加剤はコハク酸である、請求項11又は12記載の医療機器。
- 前記コハク酸はそのα−結晶多形体の形態でコーティング層中に存在する、請求項13記載の医療機器。
- バルーンカテーテル、ステント、ステントグラフト又はグラフトである、請求項1〜14のいずれか1項記載の医療機器。
- 前記治療剤及び少なくとも1つの有機添加剤を含む前記コーティング層は試験法Cを用いて、パクリタキセルの40%未満、例えば、30%未満、25%未満、20%未満、15%未満、10%未満又は5%未満が振とうの間に失われるような適切な付着性を有する、請求項1〜15のいずれか1項記載の医療機器。
- 前記機器はバルーンカテーテルであり、そして、前記コーティングは、試験法Aを用いて1時間時点で組織において測定される薬剤濃度が少なくとも50μg薬剤/g組織(μg/g)であり、例えば、少なくとも60μg/g、少なくとも70μg/g又は少なくとも80μg/gであるように、適切なパクリタキセル放出特性及び組織移行特性を有する、請求項15記載の医療機器。
- 前記機器はステントであり、そして、前記コーティングは、試験法Bを用いて24時間時点で組織において測定される薬剤濃度が少なくとも1μg薬剤/g組織(μg/g)であり、例えば、少なくとも2.5μg/g、少なくとも5μg/g又は少なくとも10μg/gであるように、パクリタキセル放出特性及び組織移行特性を有する、請求項15記載の医療機器。
- 治療剤化学含有分の少なくとも80%、例えば、少なくとも85%、90%又は95%は試験法Dを用いて、無菌化の後に保持されている、請求項1〜18のいずれか1項記載の医療機器。
- 人体の血管中の狭窄症又は再狭窄の予防又は治療における使用のための、請求項1〜
19のいずれか1項記載の医療機器。 - 治療剤及び少なくとも1つの有機添加剤を含む固体粒子状組成物であって、治療剤及び少なくとも1つの有機添加剤を含む粒子状組成物の少なくとも一部分は治療剤及び少なくとも1つの有機添加剤の純粋な形態の際の融点よりも低い温度で単一相として融解し、該治療剤はパクリタキセルであり、そして該少なくとも1つの有機添加剤は、p-アミノ安息香酸、サッカリン、アスコルビン酸、メチルパラベン、カフェイン、サリチル酸カルシウム、ペンテト酸、クレアチニン、エチル尿素、アセトアミノフェン、アスピリン、テオブロミン、トリプトファン、コハク酸、アジピン酸、グルタル酸、テオフィリン及びサッカリンナトリウムからなる群より選ばれる、固体粒子状組成物。
- 前記少なくとも1つの有機添加剤はサリチル酸カルシウム、カフェイン、メチルパラベン、p−安息香酸及びコハク酸からなる群より選ばれ、特にはコハク酸である、請求項21記載の固体粒子状組成物。
- 治療剤及び1つの有機添加剤からなる、請求項21又は22記載の固体粒子状組成物。
- 表面に適用されたコーティングの形態の、請求項21〜23のいずれか1項記載の固体粒子状組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/210,118 | 2014-03-13 | ||
US14/210,118 US11839698B2 (en) | 2014-03-13 | 2014-03-13 | Drug composition and coating |
PCT/EP2015/055366 WO2015136106A1 (en) | 2014-03-13 | 2015-03-13 | Drug composition and coating |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2017507741A JP2017507741A (ja) | 2017-03-23 |
JP2017507741A5 true JP2017507741A5 (ja) | 2018-04-19 |
JP6756620B2 JP6756620B2 (ja) | 2020-09-16 |
Family
ID=52682735
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016555997A Active JP6599882B2 (ja) | 2014-03-13 | 2015-03-13 | 埋め込み型医療用デバイス |
JP2016556946A Active JP6756620B2 (ja) | 2014-03-13 | 2015-03-13 | 薬剤組成物及びコーティング |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016555997A Active JP6599882B2 (ja) | 2014-03-13 | 2015-03-13 | 埋め込み型医療用デバイス |
Country Status (11)
Country | Link |
---|---|
US (6) | US11839698B2 (ja) |
EP (2) | EP3116581B1 (ja) |
JP (2) | JP6599882B2 (ja) |
KR (2) | KR20160132051A (ja) |
CN (2) | CN106456936B (ja) |
AU (2) | AU2015229237B2 (ja) |
BR (1) | BR112016019920A8 (ja) |
CA (2) | CA2940457C (ja) |
ES (1) | ES2874503T3 (ja) |
SG (1) | SG11201606649WA (ja) |
WO (3) | WO2015137962A1 (ja) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10806830B2 (en) | 2012-10-26 | 2020-10-20 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US10881839B2 (en) | 2012-10-26 | 2021-01-05 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US11938287B2 (en) | 2012-10-26 | 2024-03-26 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
WO2014066085A1 (en) | 2012-10-26 | 2014-05-01 | Lixiao Wang | Drug coated balloon catheters for nonvascular strictures |
US10850076B2 (en) | 2012-10-26 | 2020-12-01 | Urotronic, Inc. | Balloon catheters for body lumens |
US10898700B2 (en) | 2012-10-26 | 2021-01-26 | Urotronic, Inc. | Balloon catheters for body lumens |
US11504450B2 (en) | 2012-10-26 | 2022-11-22 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US10426588B2 (en) | 2013-12-10 | 2019-10-01 | Nova Plasma Ltd. | Container, apparatus and method for handling an implant |
US11839698B2 (en) | 2014-03-13 | 2023-12-12 | W. L. Gore & Associates, Inc. | Drug composition and coating |
US11904072B2 (en) | 2015-04-24 | 2024-02-20 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
CN118236560A (zh) | 2015-04-24 | 2024-06-25 | 优敦力公司 | 用于非血管狭窄的药物涂布的球囊导管 |
BR112017024018A2 (pt) * | 2015-05-11 | 2018-07-17 | Nova Plasma Ltd | aparelho e método para manipulação de um implante |
US20160346522A1 (en) * | 2015-06-01 | 2016-12-01 | Covidien Lp | Balloon for medical device |
GB201511284D0 (en) * | 2015-06-26 | 2015-08-12 | Univ Witwatersrand Jhb | An oral pharmaceutical dosage form for the delivery of a peptide and/or protein |
US10561766B2 (en) | 2015-09-15 | 2020-02-18 | W. L. Gore & Associates, Inc. | Drug composition and coating |
US10792477B2 (en) | 2016-02-08 | 2020-10-06 | Orbusneich Medical Pte. Ltd. | Drug eluting balloon |
US10695542B2 (en) * | 2016-04-04 | 2020-06-30 | Medtronic Vascular, Inc. | Drug coated balloon |
US20170325790A1 (en) * | 2016-05-12 | 2017-11-16 | Adn International, Llc | Single extrusion triple lumen device |
US10874768B2 (en) | 2017-01-20 | 2020-12-29 | Covidien Lp | Drug eluting medical device |
CN109414528B (zh) * | 2017-05-05 | 2022-06-24 | 优敦力公司 | 用于体腔的药物涂布球囊导管 |
US11495438B2 (en) | 2017-08-16 | 2022-11-08 | Nova Plasma Ltd. | Plasma treating an implant |
CN109663524B (zh) * | 2017-10-13 | 2022-07-15 | 分散技术有限责任公司 | 用于热动力学熔体共混批次的热敏部分的速度改变的直接进样探头感测温度方法 |
WO2019191132A1 (en) | 2018-03-27 | 2019-10-03 | The Regents Of The University Of California | Drug delivery formulations |
US10874772B2 (en) * | 2018-07-12 | 2020-12-29 | Cook Medical Technologies Llc | Coated medical device and method of coating such a device |
CN112423673A (zh) * | 2018-07-18 | 2021-02-26 | W.L.戈尔及同仁股份有限公司 | 用于分流器、闭塞器、开窗部的医疗设备以及相关的系统和方法 |
CN113727750A (zh) | 2019-02-22 | 2021-11-30 | 优敦力公司 | 用于体腔的药物涂布的球囊导管 |
US11576920B2 (en) | 2019-03-18 | 2023-02-14 | The Menopause Method, Inc. | Composition and method to aid in hormone replacement therapy |
US11478245B2 (en) | 2019-05-08 | 2022-10-25 | Covidien Lp | Surgical stapling device |
US11596403B2 (en) | 2019-05-08 | 2023-03-07 | Covidien Lp | Surgical stapling device |
KR102394776B1 (ko) * | 2020-03-02 | 2022-05-06 | 울산대학교 산학협력단 | 혈관성형술용 스텐트 |
CN111067679A (zh) * | 2020-03-02 | 2020-04-28 | 南京浩衍鼎业科技技术有限公司 | 一种具有高支撑强度的颅内可降解聚酯支架 |
CN112843343A (zh) * | 2021-01-18 | 2021-05-28 | 成都鼎峰前瞻科技有限公司 | 血液接触类功能材料、其制备方法及应用 |
CN115054727B (zh) * | 2022-06-07 | 2023-10-13 | 东华大学 | 一种贴合心脏曲面的导电心肌补片及其制备方法 |
Family Cites Families (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA962021A (en) | 1970-05-21 | 1975-02-04 | Robert W. Gore | Porous products and process therefor |
US4526714A (en) | 1982-12-13 | 1985-07-02 | Cordis Europa N.V. | Conjugates of anticoagulant and protein |
SE8200751L (sv) | 1982-02-09 | 1983-08-10 | Olle Larm | Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter |
SE456347B (sv) | 1982-02-09 | 1988-09-26 | Ird Biomaterial Ab | Ytmodifierat fast substrat samt forfarande for framstellning derav |
NL8701337A (nl) | 1987-06-09 | 1989-01-02 | Sentron V O F | Substraat voorzien van een bloedcompatibel oppervlak, verkregen door koppeling aan het oppervlak van een fysiologisch aktieve stof met remmende invloed op de vorming van bloedstolsels en/of in staat om gevormde bloedstolsels af te breken, alsmede werkwijze ter vervaardiging van het substraat. |
US5049403A (en) | 1989-10-12 | 1991-09-17 | Horsk Hydro A.S. | Process for the preparation of surface modified solid substrates |
US6165210A (en) | 1994-04-01 | 2000-12-26 | Gore Enterprise Holdings, Inc. | Self-expandable helical intravascular stent and stent-graft |
KR20010072816A (ko) | 1998-08-20 | 2001-07-31 | 쿡 인코포레이티드 | 피복된 삽입용 의료 장치 |
NO984143L (no) | 1998-09-09 | 2000-03-10 | Norsk Hydro As | Ny prosess for å fremstille overflatemodifiserende stoffer |
US7049380B1 (en) | 1999-01-19 | 2006-05-23 | Gore Enterprise Holdings, Inc. | Thermoplastic copolymer of tetrafluoroethylene and perfluoromethyl vinyl ether and medical devices employing the copolymer |
US6730349B2 (en) | 1999-04-19 | 2004-05-04 | Scimed Life Systems, Inc. | Mechanical and acoustical suspension coating of medical implants |
SE515295C2 (sv) | 1999-11-23 | 2001-07-09 | Medicarb Ab | Förfarande för framställning av konjugat av en biologiskt aktiv polysackarid och ett fast substrat, samt sådana konjugat |
US6743388B2 (en) | 2001-12-31 | 2004-06-01 | Advanced Cardiovascular Systems, Inc. | Process of making polymer articles |
US20030204168A1 (en) | 2002-04-30 | 2003-10-30 | Gjalt Bosma | Coated vascular devices |
AU2003243885B8 (en) | 2002-05-09 | 2009-08-06 | Hemoteq Ag | Medical products comprising a haemocompatible coating, production and use thereof |
US7105175B2 (en) | 2002-06-19 | 2006-09-12 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices for controlled delivery of a therapeutic agent |
US20040024448A1 (en) | 2002-08-05 | 2004-02-05 | Chang James W. | Thermoplastic fluoropolymer-coated medical devices |
US20040127551A1 (en) | 2002-12-27 | 2004-07-01 | Kai Zhang | Taxane-based compositions and methods of use |
US20050055078A1 (en) | 2003-09-04 | 2005-03-10 | Medtronic Vascular, Inc. | Stent with outer slough coating |
WO2006036982A2 (en) | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Drug delivery coating for use with a stent |
US7485140B2 (en) | 2005-06-17 | 2009-02-03 | Boston Scientific Scimed, Inc. | Bifurcation stent assembly |
US8048503B2 (en) | 2005-07-29 | 2011-11-01 | Gore Enterprise Holdings, Inc. | Highly porous self-cohered web materials |
US7655584B2 (en) | 2005-07-29 | 2010-02-02 | Gore Enterprise Holdings, Inc. | Highly porous self-cohered web materials |
ES2574780T3 (es) | 2005-09-06 | 2016-06-22 | C.R. Bard, Inc. | Injerto de liberación de fármacos |
US8585753B2 (en) | 2006-03-04 | 2013-11-19 | John James Scanlon | Fibrillated biodegradable prosthesis |
US20070212547A1 (en) | 2006-03-08 | 2007-09-13 | Boston Scientific Scimed, Inc. | Method of powder coating medical devices |
US20070212387A1 (en) | 2006-03-08 | 2007-09-13 | Sahajanand Medical Technologies Pvt. Ltd. | Coatings for implantable medical devices |
EP2023967B1 (en) | 2006-05-12 | 2017-03-22 | W. L. Gore & Associates, Inc. | Immobilized biologically active entities having a high degree of biological activity following mecanical manipulation or sterilization |
US8021677B2 (en) | 2006-05-12 | 2011-09-20 | Gore Enterprise Holdings, Inc. | Immobilized biologically active entities having a high degree of biological activity |
US9248121B2 (en) | 2006-08-21 | 2016-02-02 | Abbott Laboratories | Medical devices for controlled drug release |
WO2008023038A1 (en) | 2006-08-23 | 2008-02-28 | Blue Medical Devices Bv | Medical stent provided with a combination of melatonin and paclitaxel |
US8231929B2 (en) * | 2006-11-09 | 2012-07-31 | Cook Medical Technologies Llc | Medical device coating process |
WO2008063581A2 (en) | 2006-11-20 | 2008-05-29 | Lutonix, Inc. | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
US8414525B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US20080175887A1 (en) | 2006-11-20 | 2008-07-24 | Lixiao Wang | Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs |
US8414910B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
WO2008086490A2 (en) | 2007-01-11 | 2008-07-17 | Robert Lamar Bjork, Jr | Multiple drug-eluting coronary artery stent for percutaneous coronary artery intervention |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
DE102007036685A1 (de) * | 2007-08-03 | 2009-02-05 | Innora Gmbh | Verbesserte arzneimittelbeschichtete Medizinprodukte deren Herstellung und Verwendung |
US8906081B2 (en) | 2007-09-13 | 2014-12-09 | W. L. Gore & Associates, Inc. | Stented vascular graft |
WO2009052391A1 (en) | 2007-10-19 | 2009-04-23 | Purdue Research Foundation | Solid formulations of crystalline compounds |
US20090110713A1 (en) | 2007-10-31 | 2009-04-30 | Florencia Lim | Biodegradable polymeric materials providing controlled release of hydrophobic drugs from implantable devices |
US8029554B2 (en) * | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
DE102007059755A1 (de) | 2007-12-10 | 2009-06-18 | Biotronik Vi Patent Ag | Implantate mit membrandiffusionskontrollierter Wirkstofffreisetzung |
US8926688B2 (en) | 2008-01-11 | 2015-01-06 | W. L. Gore & Assoc. Inc. | Stent having adjacent elements connected by flexible webs |
US20090228097A1 (en) | 2008-03-07 | 2009-09-10 | Abbott Cardiovascular Systems Inc. | A1 Adenosine Receptor Antagonist-Coated Implantable Medical Device |
WO2011009096A1 (en) | 2009-07-16 | 2011-01-20 | Micell Technologies, Inc. | Drug delivery medical device |
CA2946195A1 (en) | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug delivery medical device |
GB0816783D0 (en) | 2008-09-15 | 2008-10-22 | Carmeda Ab | Immobilised biological entities |
US7819914B2 (en) | 2008-12-16 | 2010-10-26 | Cordis Corporation | Adhesion promoting primer for coated surfaces |
US20100161039A1 (en) | 2008-12-23 | 2010-06-24 | Vipul Dave | Adhesion promoting temporary mask for coated surfaces |
KR101087088B1 (ko) | 2008-12-29 | 2011-11-25 | 한국과학기술연구원 | 나노 구조 패턴을 갖는 약물 방출용 스텐트의 제조방법 및 이로부터 제조된 약물 방출용 스텐트 |
WO2010111232A2 (en) | 2009-03-23 | 2010-09-30 | Micell Technologies, Inc. | Drug delivery medical device |
EP2410954A4 (en) | 2009-03-23 | 2014-03-05 | Micell Technologies Inc | PERIPHERAL STENTS WITH LAYERS |
US8658707B2 (en) | 2009-03-24 | 2014-02-25 | W. L. Gore & Associates, Inc. | Expandable functional TFE copolymer fine powder, the expanded functional products obtained therefrom and reaction of the expanded products |
CN102481195B (zh) | 2009-04-01 | 2015-03-25 | 米歇尔技术公司 | 涂覆支架 |
WO2010121187A2 (en) | 2009-04-17 | 2010-10-21 | Micell Techologies, Inc. | Stents having controlled elution |
US8591932B2 (en) | 2009-09-17 | 2013-11-26 | W. L. Gore & Associates, Inc. | Heparin entities and methods of use |
US8887477B2 (en) | 2009-11-16 | 2014-11-18 | Cordis Corporation | E beam sterilization of medical devices comprising bioactive coating |
KR20110057796A (ko) | 2009-11-25 | 2011-06-01 | 충주대학교 산학협력단 | 헤파린과 접합되어 3원 생체분자를 이루는 항암 및 항종양 약물 전달 시스템 |
US20110144578A1 (en) | 2009-12-11 | 2011-06-16 | Stephen Pacetti | Hydrophobic therapueutic agent and solid emulsifier coating for drug coated balloon |
JP2013514278A (ja) | 2009-12-18 | 2013-04-25 | インターフェース バイオロジクス,インコーポレーテッド | 自己集合コーティングからの薬物の局所送達 |
GB201004101D0 (en) | 2010-03-12 | 2010-04-28 | Carmeda Ab | Immobilised biological entities |
DE102010022588A1 (de) | 2010-05-27 | 2011-12-01 | Hemoteq Ag | Ballonkatheter mit einer partikelfrei Wirkstoff-abgebenden Beschichtung |
US8753386B2 (en) | 2010-11-15 | 2014-06-17 | W. L. Gore & Associates, Inc. | Stent-graft having facing side branch portals |
US9839540B2 (en) | 2011-01-14 | 2017-12-12 | W. L. Gore & Associates, Inc. | Stent |
WO2012111241A1 (ja) * | 2011-02-15 | 2012-08-23 | テルモ株式会社 | ステントデリバリーシステム |
US9415193B2 (en) | 2011-03-04 | 2016-08-16 | W. L. Gore & Associates, Inc. | Eluting medical devices |
US20120310210A1 (en) | 2011-03-04 | 2012-12-06 | Campbell Carey V | Eluting medical devices |
US9101696B2 (en) | 2011-03-11 | 2015-08-11 | W.L. Gore & Associates, Inc. | Immobilised biological entities |
US8628968B2 (en) | 2011-03-30 | 2014-01-14 | La-Co Industries, Inc. | Ethylene oxide sterilization indicator compositions |
US9061127B2 (en) | 2011-04-29 | 2015-06-23 | Boston Scientific Scimed, Inc. | Protective surfaces for drug-coated medical devices |
EP2540293A1 (de) | 2011-06-28 | 2013-01-02 | Biotronik AG | Erhöhung der effizienz der therapeutischen Wirkung pharmakologischer Wirsktoff-freissetzender medizinischer Vorrichtungen |
GB201113662D0 (en) | 2011-08-08 | 2011-09-21 | Prosonix Ltd | Pharmaceutical compositions |
US9775933B2 (en) | 2012-03-02 | 2017-10-03 | W. L. Gore & Associates, Inc. | Biocompatible surfaces and devices incorporating such surfaces |
US20140142682A1 (en) | 2012-08-10 | 2014-05-22 | W.L. Gore & Associates, Inc | Implantable biocompatible tubular material |
US9198999B2 (en) | 2012-09-21 | 2015-12-01 | Merit Medical Systems, Inc. | Drug-eluting rotational spun coatings and methods of use |
US9931193B2 (en) | 2012-11-13 | 2018-04-03 | W. L. Gore & Associates, Inc. | Elastic stent graft |
CA2956502C (en) | 2013-01-04 | 2020-02-25 | W.L. Gore & Associates, Inc. | Implantable intralumenal device |
US20140277381A1 (en) | 2013-03-14 | 2014-09-18 | W. L. Gore & Associates, Inc. | Methods and apparatus for assembling stent-grafts |
DE102013106463A1 (de) | 2013-06-20 | 2014-12-24 | Jotec Gmbh | Stentgraft |
CN103691007B (zh) | 2013-12-16 | 2014-12-17 | 安毅 | 一种温敏水凝胶复合涂层血管支架的制备方法 |
US11839698B2 (en) | 2014-03-13 | 2023-12-12 | W. L. Gore & Associates, Inc. | Drug composition and coating |
-
2014
- 2014-03-13 US US14/210,118 patent/US11839698B2/en active Active
- 2014-03-14 WO PCT/US2014/027304 patent/WO2015137962A1/en active Application Filing
-
2015
- 2015-03-13 CN CN201580024790.XA patent/CN106456936B/zh active Active
- 2015-03-13 WO PCT/US2015/020390 patent/WO2015138862A1/en active Application Filing
- 2015-03-13 JP JP2016555997A patent/JP6599882B2/ja active Active
- 2015-03-13 CA CA2940457A patent/CA2940457C/en active Active
- 2015-03-13 KR KR1020167027545A patent/KR20160132051A/ko active IP Right Grant
- 2015-03-13 WO PCT/EP2015/055366 patent/WO2015136106A1/en active Application Filing
- 2015-03-13 ES ES15709943T patent/ES2874503T3/es active Active
- 2015-03-13 US US15/125,635 patent/US20170014553A1/en not_active Abandoned
- 2015-03-13 BR BR112016019920A patent/BR112016019920A8/pt not_active Application Discontinuation
- 2015-03-13 EP EP15718391.4A patent/EP3116581B1/en active Active
- 2015-03-13 US US15/125,668 patent/US20170360991A1/en not_active Abandoned
- 2015-03-13 SG SG11201606649WA patent/SG11201606649WA/en unknown
- 2015-03-13 EP EP15709943.3A patent/EP3116579B1/en active Active
- 2015-03-13 AU AU2015229237A patent/AU2015229237B2/en active Active
- 2015-03-13 JP JP2016556946A patent/JP6756620B2/ja active Active
- 2015-03-13 CN CN201580013481.2A patent/CN106102785B/zh active Active
- 2015-03-13 KR KR1020167025044A patent/KR102486231B1/ko active IP Right Grant
- 2015-03-13 CA CA2938482A patent/CA2938482C/en active Active
- 2015-03-13 AU AU2015228785A patent/AU2015228785B2/en active Active
- 2015-09-14 US US14/852,749 patent/US20160000977A1/en not_active Abandoned
- 2015-09-14 US US14/852,772 patent/US20160015870A1/en not_active Abandoned
- 2015-09-14 US US14/852,708 patent/US20160015868A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2017507741A5 (ja) | ||
JP2017513545A5 (ja) | ||
HRP20201216T1 (hr) | PRIPRAVCI I POSTUPCI ZA LIJEČENJE POREMEĆAJA CNS-a | |
TW202043198A (zh) | 用於治療與sting活性相關之病況的化合物及組合物 | |
RU2020112759A (ru) | Гетероциклические соединения в качестве ингибиторов PAD | |
JP2018516935A (ja) | チロシンキナーゼ阻害剤 | |
RU2470642C2 (ru) | Аналоги птерина для лечения состояния, чувствительного к вн4 | |
RU2005103226A (ru) | Новые соединения, составы и способы лечения воспалительных заболеваний и состояний | |
JP2017511360A5 (ja) | ||
US11040037B2 (en) | Therapeutic agents and methods | |
JP2017533930A5 (ja) | ||
JP2018527287A5 (ja) | ||
RU2017142958A (ru) | Кристаллы азабициклического соединения | |
JP2017533220A5 (ja) | ||
WO2009027069A3 (de) | Osmolyte zur behandlung von allergisch oder viral bedingten atemwegserkrankungen | |
JP2017530211A5 (ja) | ||
WO2022015938A1 (en) | Compounds and compositions for treating conditions associated with sting activity | |
JP2014530882A5 (ja) | ||
JP2017533935A5 (ja) | ||
JP2017008001A5 (ja) | ||
EP4263531A2 (en) | Compounds and compositions for treating conditions associated with sting activity | |
JP4807687B2 (ja) | 塩基性疎水性医薬化合物の医薬組成物の製造法 | |
RU2018114922A (ru) | Лечение очаговой алопеции | |
RU2017134794A (ru) | Комбинированная лекарственная форма антагониста мю-опиоидного рецептора и опиоидного средства | |
EP3189838A1 (en) | Pharmaceutical composition for inhibiting formation of thrombi and emboli after placement of stent |